Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.0%

1 terminated out of 51 trials

Success Rate

97.0%

+10.5% vs benchmark

Late-Stage Pipeline

18%

9 trials in Phase 3/4

Results Transparency

6%

2 of 32 completed with results

Key Signals

2 with results97% success

Data Visualizations

Phase Distribution

48Total
Not Applicable (35)
Early P 1 (1)
P 1 (1)
P 2 (2)
P 3 (1)
P 4 (8)

Trial Status

Completed32
Unknown10
Not Yet Recruiting3
Active Not Recruiting2
Terminated1
Recruiting1

Trial Success Rate

97.0%

Benchmark: 86.5%

Based on 32 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT07550751Phase 4CompletedPrimary

Optimal Dosage of Melatonin for Preoperative Sedation in FESS

NCT04691700Phase 4Active Not Recruiting

GOREISAN for Heart Failure (GOREISAN-HF) Trial

NCT06974968Phase 2Not Yet Recruiting

Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial

NCT06526312Not ApplicableRecruitingPrimary

Primary Care Evidence-based Approach for Improving Lifelong Health

NCT07081529Not ApplicableCompletedPrimary

Clinical Evaluation of Class I Direct and Indirect Restorations Over 10 Years

NCT07017296Not ApplicableCompletedPrimary

Microencapsulated Pomegranate Juice as Anti-Hypertensive

NCT06037603Not ApplicableCompleted

Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)

NCT04469816Not ApplicableCompletedPrimary

AFRI Childhood Obesity Prevention Challenge Area

NCT04237298Not ApplicableCompleted

Comparison of Modified Vacuum-formed Retainers Versus Hawley Retainer

NCT03891433Phase 4Suspended

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae

NCT06562387Not ApplicableActive Not RecruitingPrimary

tDCS as Adjunctive Therapy to Cognitive Stimulation in Medical Students With Depression

NCT06556030Phase 4Not Yet Recruiting

A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.

NCT06549582Not ApplicableNot Yet Recruiting

Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients

NCT03013309Not ApplicableCompletedPrimary

Raising Healthy Children: A Hybrid Trial of the Family Check-Up 4 Health in Primary Care

NCT04937803Not ApplicableCompleted

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

NCT05635539Not ApplicableCompletedPrimary

Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial

NCT04437836Phase 1CompletedPrimary

Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic

NCT06254170Not ApplicableUnknownPrimary

Supplementation Performance And Exercise With Euterpe Edulis for Men's Enhancement

NCT05776329Not ApplicableCompleted

Dietary Intervention to Reduce Metabolic Endotoxemia

NCT04719221Phase 4UnknownPrimary

Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome

Scroll to load more

Research Network

Activity Timeline